Governance: breaking the board apart

Jun 01, 2006
<p>US companies are separating their top responsibilities at a faster rate than ever before, with shareholder activists often fueling changes</p>
In March, shareholder activists once again filed a proxy proposal asking Pfizer to split the roles of CEO and chairman of the board. Charles Raeburn, Pfizer’s senior corporate counsel, says a similar proposal garnered 41 percent of the shareholder vote last year,

Content Preview

to continue reading

Sign up to get stories direct to your inbox
logo-black logo-black